Tech Company Financing Transactions
BigHat Biosciences Funding Round
On 9/24/2026, BigHat Biosciences raised $75 million in Series C funding from DFJ Growth, Premji Invest and 8VC.
Transaction Overview
Company Name
Announced On
9/24/2026
Transaction Type
Venture Equity
Amount
$75,000,000
Round
Series C
Investors
DFJ Growth (Lead Investor) (Justin Kao)
Premji Invest (Lead Investor) (Marc Casas)
Alexandria Venture Investments
Proceeds Purpose
The financing will support continued growth of BigHat's leading platform for rapid data generation to power frontier intelligence for protein design, as well as advancement of the company's pipeline of AI-designed therapeutics, including BHB810 and BHB299, to key clinical readouts.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
733 Industrial Rd.
San Carlos, CA 94070
USA
San Carlos, CA 94070
USA
Phone
Undisclosed
Website
Email Address
Overview
BigHat's mission is to improve human health by making it far easier to design advanced, next-generation antibody therapeutics. Our AI-enabled experimental platform integrates a high-speed characterization or wet lab with machine learning technologies to speed the antibody engineering process.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mark DePristo
Chief Scientific Officer
Peyton Greenside
VP - Bus. Development
Elizabeth Schwarzbach
VP - Engineering
Eddie Abrams
Browse more venture capital transactions:
Prev: 9/24/2026: PicoJool venture capital transaction
Next: 9/24/2026: EnginZyme venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on all VC transactions involving tech companies. All VC database entries reported here come from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs